1. |
中国医师协会心血管内科医师分会结构性心脏病专业委员会. 经导管主动脉瓣置换术中国专家共识(2020更新版). 中国介入心脏病学杂志, 2020, 28(6): 301-309.
|
2. |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation, 2021, 143(5): e35-e71.
|
3. |
潘文志, 龙愉良, 周达新, 等. 2020年经导管瓣膜治疗主要进展. 中国胸心血管外科临床杂, 2021, 28(4): 371-375.
|
4. |
徐先增. 经导管主动脉瓣植入术并发症研究进展. 微创医学, 2012, 7(4): 403-406.
|
5. |
Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: A population-based study. Lancet, 2006, 368(9540): 1005-1011.
|
6. |
Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol, 2020, 76(21): 2492-2516.
|
7. |
Lester SJ, Heilbron B, Gin K, et al. The natural history and rate of progression of aortic stenosis. Chest, 1998, 113(4): 1109-1114.
|
8. |
Stouffer GA, Lenihan DJ, Lerakis S, et al. Timing of aortic valve surgery in chronic aortic stenosis and regurgitation. Am J Med Sci, 2004, 327(6): 348-351.
|
9. |
Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J, 2012, 33(19): 2451-2496.
|
10. |
Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 2017, 38(36): 2739-2791.
|
11. |
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
|
12. |
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med, 2019, 380(18): 1695-1705.
|
13. |
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
|
14. |
葛均波, 周达新, 潘文志, 等. 经皮主动脉瓣植入术一例及其附操作要点. 中国介入心脏病学杂志, 2010, 18(5): 243-246.
|
15. |
Otto CM, Kumbhani DJ, Alexander KP, et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: A report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol, 2017, 69(10): 1313-1346.
|
16. |
Auffret V, Puri R, Urena M, et al. Conduction disturbances after transcatheter aortic valve replacement: Current status and future perspectives. Circulation, 2017, 136(11): 1049-1069.
|
17. |
Sawaya FJ, Lefèvre T, Spaziano M, et al. Transfemoral transcatheter aortic valve implantation: How minimalistic can we become? J Interv Cardiol, 2016, 29(6): 628-631.
|
18. |
张昆, 孙路路, 张耀霞, 等. 经导管主动脉瓣置入术不同手术路径8例的护理配合. 心血管外科杂志(电子版), 2015, 4(1): 43-45.
|
19. |
Rodés-Cabau J, Ellenbogen KA, Krahn AD, et al. Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC scientific expert panel. J Am Coll Cardiol, 2019, 74(8): 1086-1106.
|
20. |
Siontis GC, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: A meta-analysis. J Am Coll Cardiol, 2014, 64(2): 129-140.
|
21. |
Liao YB, Zhao ZG, Wei X, et al. Transcatheter aortic valve implantation with the self-expandable Venus A-Valve and CoreValve devices: Preliminary experiences in China. Catheter Cardiovasc Interv, 2017, 89(S1): 528-533.
|
22. |
Zhou D, Pan W, Wang J, et al. VitaFlowTM transcatheter valve system in the treatment of severe aortic stenosis: One-year results of a multicenter study. Catheter Cardiovasc Interv, 2020, 95(2): 332-338.
|